Home > Insider Trading > Filing (0001127602-21-028299)

Filing Details

Accession Number:: 0001127602-21-028299
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-03 16:36:57
Reporting Period:: 2021-11-01

Accepted Time:: 2021-11-03 16:36:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1387890	Mark Stevenson	168 Third Avenue Waltham MA 02451	Executive Vice President & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-01	14,550	$190.59	73,806	No	4	M	Direct
Common Stock	Acquisiton	2021-11-01	12,375	$157.68	86,181	No	4	M	Direct
Common Stock	Disposition	2021-11-01	1,570	$628.61	84,611	No	4	S	Direct
Common Stock	Disposition	2021-11-01	2,000	$629.71	82,611	No	4	S	Direct
Common Stock	Disposition	2021-11-01	4,141	$630.69	78,470	No	4	S	Direct
Common Stock	Disposition	2021-11-01	3,769	$631.72	74,701	No	4	S	Direct
Common Stock	Disposition	2021-11-01	2,367	$632.70	72,334	No	4	S	Direct
Common Stock	Disposition	2021-11-01	6,169	$633.92	66,165	No	4	S	Direct
Common Stock	Disposition	2021-11-01	5,209	$634.71	60,956	No	4	S	Direct
Common Stock	Disposition	2021-11-01	900	$635.78	60,056	No	4	S	Direct
Common Stock	Disposition	2021-11-01	800	$636.82	59,256	No	4	S	Direct
Common Stock	Acquisiton	2021-11-02	14,550	$190.59	73,806	No	4	M	Direct
Common Stock	Acquisiton	2021-11-02	12,375	$157.68	86,181	No	4	M	Direct
Common Stock	Disposition	2021-11-02	500	$633.27	85,681	No	4	S	Direct
Common Stock	Disposition	2021-11-02	1,500	$635.09	84,181	No	4	S	Direct
Common Stock	Disposition	2021-11-02	5,004	$635.92	79,177	No	4	S	Direct
Common Stock	Disposition	2021-11-02	4,008	$636.90	75,169	No	4	S	Direct
Common Stock	Disposition	2021-11-02	3,682	$638.01	71,487	No	4	S	Direct
Common Stock	Disposition	2021-11-02	5,741	$639.06	65,746	No	4	S	Direct
Common Stock	Disposition	2021-11-02	3,848	$640.00	61,898	No	4	S	Direct
Common Stock	Disposition	2021-11-02	2,033	$640.97	59,865	No	4	S	Direct
Common Stock	Disposition	2021-11-02	609	$642.26	59,256	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-01	14,550	$0.00	14,550	$190.59
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-01	12,375	$0.00	12,375	$157.68
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-02	14,550	$0.00	14,550	$190.59
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-02	12,375	$0.00	12,375	$157.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,100	2021-03-07	2024-09-07	No	4	M	Direct
24,750		2024-02-28	No	4	M	Direct
14,550	2021-03-07	2024-09-07	No	4	M	Direct
12,375		2024-02-28	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	477	Indirect	By 401(k)
Common Stock	5,320	Indirect	By Grace S. Stevenson Irrevocable Trust
Common Stock	5,320	Indirect	By Matthew L. Stevenson Irrevocable Trust
Common Stock	5,320	Indirect	By Jack A. Stevenson Irrevocable Trust
Common Stock	22,100	Indirect	By GRAT
Common Stock	29,959	Indirect	By Stevenson 2010 Living Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.08 to $629.06, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.21 to $630.16, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.23 to $631.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.25 to $632.23, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.30 to $633.25, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.31 to $634.30, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.31 to $635.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.44 to $636.415, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.70 to $637.215, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.79 to $633.415, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.46 to $635.39, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.46 to $636.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.47 to $637.41, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.51 to $638.50, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.51 to $639.47, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.51 to $640.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.65 to $641.34, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.99 to $642.88, inclusive.
The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.